Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-25

Clinical Trial Update: Topical Periplaneta Americana-Derived Meilian Fuxin Liquid for Radiation Dermatitis [Phase 2, Phase 3]

View source ↗

Summary

A topical formulation called Meilian Fuxin Liquid, derived from Periplaneta americana, is being studied for radiation-induced dermatitis in Phase 2/Phase 3 tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Meilian Fuxin Liquid (Periplaneta americana-derived topical formulation)

Snippet

Sponsor: West China Hospital | Conditions: Radiation-induced Dermatitis | Phase 2, Phase 3 | Status: RECRUITING